Latest Clinuvel Pharmaceuticals (ASX:CUV) News
Page 1
Page 1 of 3
Clinuvel maps A$220 million transformation as CUV107 slips to February
6 Nov 2026
Clinuvel files European dossier for second pharmaceutical product
30 Oct 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Clinuvel Reports Tenth Profit, Plans Nasdaq Listing and U.S. HQ Move
27 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Clinuvel Sets December 2026 for Vitiligo Trial Results, Phase III to Start November
28 July 2026
Market Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
Healthcare Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
CLINUVEL Shifts Headquarters to US and Cuts Workforce to Target US Market
23 July 2026
Market Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Health Canada Grants Approval for CLINUVEL’s SCENESSE to Treat Rare EPP Disorder
13 July 2026